| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Rifampicin was introduced in 1967,as a major addition to the cocktail drug treatment of tuberculosis and inactive meningitis,along with pyrazinamide,isoniazid,ethambutol and streptomycin ("PIERS"). Rifampicin requires a prescription in North America. Rifampicin must be administered regularly daily for several months without break;otherwise,the risk of drug resistant tuberculosis is greatly increased.
In fact, Rifampicin is the primary reason it is used in tandem with the three aforementioned drugs, particularly isoniazid.Rifampicin is also the primary motivation behind directly observed therapy for tuberculosis.Rifampicin resistance develops quickly during treatment,so monotherapy should not be used to treat these infections - Rifampicin should be used in combination with other antibiotics
| Item | Test Standard | Testing Result | |
| Assay | 99% | Complies | |
| Apperence | Red Powder | Complies | |
| Particle Size | 100% pass 80 mesh | Complies | |
| Oder | Characteristic | Complies | |
| Taste | Characteristic | Complies | |
| Loss on Drying | ≤5.0% | 2.20% | |
| Residue on Ignition | ≤0.1% | 0.05% | |
| Residual | ≤0.1% | Complies | |
| Residual Ethanol | ≤0.5% | Complies | |
| Heave Mentals | ≤10ppm | Complies | |
| Na | ≤0.1% | <0.1% | |
| Pb | ≤3 ppm | Complies | |
| Total Plate | <1000CFU/g | Complies | |
| Yeast & Mold | <100 CFU /g | Complies | |
| E. Coli | Negative | Complies | |
| Salmonella | Negative | Complies | |
){kind=link}